18 h pretreatment incubation, progesterone, PGE2 and oxytocin production was similar between the prospective treatment groups. Progesterone production was greater (P< 0.001) 
Introduction
Pregnancy-specific protein (PSPB) has been used successfully as the target antigen in the development of a radioimmuno¬ assay for pregnancy determination in many domestic and wildlife species, including cattle (Sasser et al, 1986 (Sasser et al, , 1989 Haigh et al, 1993; Willard et al, 1994) . Despite knowledge of its presence and specificity to pregnancy in these species, studies designed to test the physiological function(s) of this protein are only now being carried out (Del Vecchio et al, 1990 , 1995a  positive feedback loop needs to be interrupted. PSPB may help to mediate this process by modifying luteal cell oxytocin secretion and hence compromising the positive feedback loop resulting in extension of the lifespan of the corpus luteum. In addition, PSPB may also act as a luteotrophic and luteoprotective agent, again resulting in maintenance of the corpus luteum of pregnancy.
This study was designed to complement previous work (Del Vecchio et al., 1995a, b) by: (1) testing the effects of PSPB alone on luteal cell progesterone, PGE2 and oxytocin produc¬ tion; and (2) determining whether PSPB interacts with PGF2o to alter luteal cell progesterone, PGE2 and oxytocin production, during both the mid-and late-luteal stages of the bovine oestrous cycle. Company. Intra-assay and interassay coefficients of variation were 5.9 and 14.3%, respectively.
The concentration of oxytocin in the culture medium was measured directly by radioimmunoassay (Sheldrick and Flint, 1981) . Anti-oxytocin antibody was generously pro¬ vided by D. Schams (Freising) and used at a dilution of 1:37 500. Crossreactivity of the oxytocin antisera was reported by Schams (1983) . Synthetic oxytocin for the standard curves was purchased from Sigma Chemical Company.
Oxytocin I25I-labelled Tyr2 was purchased from Dupont Chemical Company (Mississauga, ON). Intra-assay and inter¬ assay coefficients of variation were 6.5 and 12.6%, respectively.
Statistical analyses
All data were analysed using general linear models pro¬ cedure of SAS (1985) . The data were transformed to squareroots to stabilize the variance before statistical analysis (Kleinbaum and Küpper, 1978 (Fig. lb) . However, treatment with PSPB increased (P < 0.02) luteal cell progesterone produc¬ tion at the 5.0 µg dose as compared with the controls; the effect of the 2.5 µg dose was intermediate (Fig. lc) (Fig. 2a) . Production of PGE2 decreased (P < 0.001) with increased incubation time, that is, between the 6 and 12 h incubation times (Fig. 2a) . Luteal cell PGE2 production increased similarly in response to the 2.5 and 5.0 µg treatment doses of PSPB treatment (P<0.01; Fig. 2b) compared with the controls. In addition, both the 100 and 200 ng treatment doses of PGF2(Z increased (P < 0.001) PGE2 production ( Fig. 2c) (Fig. 3a) and PSPB ( Fig. 3b) (Fig. 3c) (Del Vecchio et al, 1995b) . Chegini et al. (1991) showed that both small and large bovine luteal cells contain binding sites for PGE2, PGF2(1, PGI2, leukotriene C4 and hCG/LH. In addition, Milvae and Hansel (1983) , Hu et al (1990) and Townson and Pate (1994) and our data show that bovine luteal cells actively secrete a variety of prostaglandins. Milvae and Hansel (1985) showed that by blocking uterine and ovarian prostaglandin production with indomethacin, the development and function given the data reported thus far concerning the effect of PSPB on luteal prostaglandin production, both in this study and an earlier study (Del Vecchio et al, 1995a) , it may be possible that PSPB increased luteal PGE2 production, and the increased PGE2 It was expected that PGF2n would decrease luteal progester¬ one production; however, no effect was detected in this study. Although PGF2(1 is considered the endogenous luteolysin, other work in vitro has shown that PGF2u has little or no effect on progesterone production (Pate and Condon, 1984) . In fact some researchers have reported a stimulatory effect of PGF2ü on bovine luteal cell progesterone production (Alila et al, 1988b; Hansel et al, 1991) (Pate, 1994) , and the luteolytic effect/action of PGF2u seems to be restricted to the large luteal cells. However, when PGF2(1 treatment is administered alone it appears to have little effect on proges¬ terone production, but PGF2lI does seem to inhibit the LH-, PGE2-and PGI,-stimulated production of progesterone (Alila et al, 1988b; Pate, 1994 These data agree with previous data (Del Vecchio el al, 1995a , b) that PSPB does not affect oxytocin production by cultured bovine luteal cells. Therefore, the likelihood that PSPB alters luteal cell release of oxytocin, thereby compromising the integrity of the proposed positive feedback loop mechanism of cyclic luteal regression and favouring maintenance of the corpus luteum, is not supported. In addition, PGF2a had no effect on luteal cell oxytocin production in this study. Prosta¬ glandin F2a has been shown to cause an increase in luteal oxytocin production when administered to intact tissue, that is, intact corpora lutea or luteal slices in vitro (Abdelgadir el al, 1987 (Abdelgadir el al, , 1994 and dispersed luteal cells (Lafrance and Hansel, 1992 (Abdelgadir et al, 1987) . Similar data have been reported for ewes (Cooke and Ahmad, 1994 
